Successful Completion of $10m Institutional Portion of Offer
Filed with ASX · · 5 pages · English
Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of ImpediMed (ASX:IPD) Q1 2027 Earnings CallStory so far
Earlier from ImpediMed
- Prospectus
- ImpediMed Secures Order from Large US Oncology Care Network
- New National Purchasing Agreement for Lymphoedema Prevention
- Baylor Scott & White Expands SOZO Use with New iOS Software
- Appendix 4D and Interim Financial Report (Signed)
Later from ImpediMed
- ImpediMed Releases Heart Failure and Renal Disease Software
- Appendix 4C - Quarter ended 31 March 2020
- Change in substantial holding
- Independent BIS RE-AIM Analysis to be Released at ASCO 2020
- NSW Health Expands SOZO Use for Lymphoedema Prevention
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed